Cannara Biotech Inc. (TSXV: LOVE)

Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	77	61	90	118	149	70
Market Cap Growth	-32.29%	-32.29%	-23.64%	-20.54%	112.60%	-36.02%
Enterprise Value	118	105	131	146	160	74
Last Close Price	0.85	0.68	1.00	1.35	1.70	0.95
PE Ratio	12.14	9.51	13.02	51.35	-	-
PS Ratio	0.94	0.75	1.58	3.30	8.75	27.48
PB Ratio	0.87	0.70	1.13	1.77	2.32	1.83
P/TBV Ratio	0.70	0.70	1.13	1.77	2.32	1.83
P/FCF Ratio	23.81	19.05	-	-	-	-
P/OCF Ratio	5.73	5.73	15.29	-	-	-
EV/Sales Ratio	1.45	1.28	2.29	4.07	9.40	29.09
EV/EBITDA Ratio	8.45	7.62	7.92	16.91	58.11	-
EV/EBIT Ratio	15.47	13.69	11.17	30.25	3041.18	-
EV/FCF Ratio	36.78	32.55	-	-	-	-
Debt / Equity Ratio	0.55	0.55	0.57	0.73	0.33	0.34
Debt / EBITDA Ratio	3.45	3.45	2.75	5.54	7.15	-
Debt / FCF Ratio	15.04	15.04	-	-	-	-
Asset Turnover	0.55	0.55	0.43	0.33	0.23	0.04
Inventory Turnover	1.41	1.41	1.14	1.40	1.39	1.09
Quick Ratio	0.73	0.73	0.70	1.75	1.63	2.32
Current Ratio	2.50	2.50	2.44	3.46	2.82	3.03
Return on Equity (ROE)	7.68%	7.68%	9.48%	3.52%	-2.98%	-29.66%
Return on Assets (ROA)	3.22%	3.22%	5.48%	2.77%	0.04%	-12.16%
Return on Capital (ROIC)	3.65%	3.65%	6.09%	3.01%	0.05%	-13.06%
Earnings Yield	8.24%	10.52%	7.68%	1.95%	-1.03%	-17.81%
FCF Yield	4.20%	5.25%	-4.39%	-18.20%	-22.26%	-26.41%
Buyback Yield / Dilution	-1.83%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%
Total Shareholder Return	-1.83%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%

Source: S&P Capital IQ. Standard template. Financial Sources.